# Baxter Oncology GmbH - Inspection Records

Source: https://www.keypedia.com/companies/baxter-oncology-gmbh/43dd5bdb-ca73-4678-ba1f-6ef4b5400e06

> Inspection records and compliance data for Baxter Oncology GmbH in Halle (Westf.), None. Access full analysis and detailed observations.

---

## Details

- Name: Baxter Oncology GmbH
- FEI Number: 3002806419
- City: Halle (Westf.)
- State: None
- Country Name: Germany
- Address Line 1: Kantstr. 2
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Baxter Oncology GmbH - 2025-09-26](https://www.keypedia.com/records/483/baxter-oncology-gmbh/0d86bbfe-7f41-475c-961e-6a5a661fc1f6) — source: FDA, date: September 26, 2025
- [FDA Inspection 1283802 - Baxter Oncology GmbH - 2025-09-26](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/d2cc3497-33d6-41da-be71-fed681081e29) — classification: Official Action Indicated (OAI), source: FDA, date: September 26, 2025
- [483 - Baxter Oncology GmbH - 2025-09-18](https://www.keypedia.com/records/483/baxter-oncology-gmbh/32f7c539-e5e8-476d-a76c-af73f8619534) — source: FDA, date: September 18, 2025
- [EIR - Baxter Oncology GmbH - 2024-08-27](https://www.keypedia.com/records/eir/baxter-oncology-gmbh/926cf150-be1f-4e3c-8bcc-c1595173865d) — source: FDA, date: August 27, 2024
- [483 - Baxter Oncology GmbH - 2024-08-27](https://www.keypedia.com/records/483/baxter-oncology-gmbh/2af708b1-9a7e-4ae2-970f-cadc4ee74ce6) — source: FDA, date: August 27, 2024
- [483 - Baxter Oncology GmbH - 2024-08-27](https://www.keypedia.com/records/483/baxter-oncology-gmbh/270239ed-c98e-4bdd-8d78-095067105231) — source: FDA, date: August 27, 2024
- [FDA Inspection 1249702 - Baxter Oncology GmbH - 2024-08-27](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/8f606d21-cc2a-4cf4-813d-420b7e93dccc) — source: FDA, date: August 27, 2024
- [FDA Inspection 1206312 - Baxter Oncology GmbH - 2023-05-03](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/49ff9f86-3d55-44a7-abeb-1a0511f483b6) — classification: No Action Indicated (NAI), source: FDA, date: May 3, 2023
- [FDA Inspection 1161093 - Baxter Oncology GmbH - 2020-01-29](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/a02d317d-bca9-4a63-ac97-f10e78abf4af) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2020
- [483 - Baxter Oncology GmbH - 2019-11-05](https://www.keypedia.com/records/483/baxter-oncology-gmbh/f8379713-5f2d-4c65-9d44-6d8d24e6bc75) — source: FDA, date: November 5, 2019
- [FDA Inspection 1106642 - Baxter Oncology GmbH - 2019-09-03](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/65040e4f-1fd6-4b4b-acff-6fa84596b810) — classification: No Action Indicated (NAI), source: FDA, date: September 3, 2019
- [483 - Baxter Oncology GmbH - 2018-08-20](https://www.keypedia.com/records/483/baxter-oncology-gmbh/44a76868-527b-4e97-8b39-bf984e859eb6) — source: FDA, date: August 20, 2018
- [483 - Baxter Oncology GmbH - 2018-06-14](https://www.keypedia.com/records/483/baxter-oncology-gmbh/45f622cd-5fa3-459c-95b0-544a8450e0d7) — source: FDA, date: June 14, 2018
- [FDA Inspection 1056958 - Baxter Oncology GmbH - 2018-06-14](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/9da172d1-9118-487f-b26d-5b064e49e5f1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2018
- [FDA Inspection 1019700 - Baxter Oncology GmbH - 2017-06-27](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/64eef675-4ce9-4232-82e4-ae06945fe393) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2017
- [FDA Inspection 967376 - Baxter Oncology GmbH - 2016-03-18](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/cee1839e-90d4-436f-a2f1-187376c7dc5a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 18, 2016
- [FDA Inspection 888909 - Baxter Oncology GmbH - 2014-07-01](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/2b6bc808-5b18-4a6f-8773-dafad9780c6c) — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2014
- [FDA Inspection 845264 - Baxter Oncology GmbH - 2013-07-20](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/71d0a6b8-a346-427c-bedb-4a918d351e05) — classification: No Action Indicated (NAI), source: FDA, date: July 20, 2013

## Related Companies

- [Bayer AG](https://www.keypedia.com/companies/bayer-ag/c999165f-4c13-4f49-b979-087064975cb0)
- [IDT Biologika GmbH](https://www.keypedia.com/companies/idt-biologika-gmbh/ec3af185-e1cd-4ce4-9268-6cbfb25fa986)
- [SUNNY PHARMTECH INC.](https://www.keypedia.com/companies/sunny-pharmtech-inc/ef1ee573-efce-4b46-a67b-b9dfafc78f82)
- [Shandong New Time Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/shandong-new-time-pharmaceutical-co-ltd/470fe860-121a-4594-b9a5-e6bf05ce1926)
- [Hamari PFST, Ltd.](https://www.keypedia.com/companies/hamari-pfst-ltd/17548bf6-b8d5-4469-be75-78ca6f0f7bd5)
- [GlaxoSmithKline Biologicals SA](https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/ef569005-49c7-4bf9-b3f1-7814705bec8e)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [Lyocontract GmbH](https://www.keypedia.com/companies/lyocontract-gmbh/0c56698a-6a88-4c94-9de9-6e9f5172cf27)
- [Suzhou Union Biopharm Co., Ltd.](https://www.keypedia.com/companies/suzhou-union-biopharm-co-ltd/5d9c9c07-1afc-44da-b4ff-872317d01143)
- [Steriscience SP. Z O.O.](https://www.keypedia.com/companies/steriscience-sp-z-oo/a2c32aee-8f5f-4bd3-8cc9-9fdcf970ebf4)

## Related Officers

- [Luis M. Burgos](https://www.keypedia.com/people/luis-m-burgos/0fd6ed19-ed70-474b-86eb-f54fa7f7d1a0)
- [Regulatory Counsel, CDER Compliance, Office of Manufacturing Quality](https://www.keypedia.com/people/emilie-e-kahn/fac179e5-478f-4e75-9632-40d921f44a8f)
- [Plant Manager](https://www.keypedia.com/people/frank-generotzky/1ca5dbec-c26e-43c4-9eaa-69b0dd2b796f)
- [Virginia A. Carroll](https://www.keypedia.com/people/virginia-a-carroll/180e8c1a-1712-4701-9399-9758573ef8d8)
- [Zhong Li](https://www.keypedia.com/people/zhong-li/18545b20-7fa5-4850-9dd4-cffb40c41f8d)
